Diagnosis of COVID-19 with enhanced real-time mass spectrometry breath analysis
Camille Roquencourt(Hôpital Foch), Stanislas Grassin‐Delyle(Inserm), Philippe Devillier(Inserm), Emmanuelle Bardin(Inserm), Naline Emmanuel(Hôpital Foch), Elodie Lamy(Inserm), Éric Farfour(Délégation Paris 5), Hélène Salvator(Université Paris-Saclay)
Cited by 0
Related Papers
<i>Pseudomonas aeruginosa</i>infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches
|Expert Review of Respiratory Medicine|2016|170
Evaluation of the Andromas Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry System for Identification of Aerobically Growing Gram-Positive Bacilli
|Journal of Clinical Microbiology|2012|137
Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosis
|FEMS Microbiology Letters|2017|107
Modulators of CFTR. Updates on clinical development and future directions
|European Journal of Medicinal Chemistry|2021|67